Clinical Trial Update: Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia [Phase 1]

View source ↗

Summary

Phase 1 study of Calcitriol, USP (Compound 31543) in patients receiving taxane-based chemotherapy for chemotherapy-induced alopecia. The trial is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Alopecia

Drugs mentioned

• Calcitriol, USP (Calcitriol)

Snippet

Sponsor: BPGbio | Conditions: Chemotherapy-Induced Alopecia | Phase 1 | Status: COMPLETED | Results posted: 2025-05-28